Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.
about
Pre-treatment Serum Lactate Dehydrogenase is Predictive of Survival in Patients with Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiotherapy.Efficacy and Safety of Chemotherapy Combined with Stereotactic Radiotherapy in the Treatment of Nasopharyngeal Carcinoma.Cofilin-2 Acts as a Marker for Predicting Radiotherapy Response and Is a Potential Therapeutic Target in Nasopharyngeal Carcinoma.
P2860
Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pretreatment Serum Lactate Deh ...... dulated Radiation Therapy Era.
@en
Pretreatment Serum Lactate Deh ...... dulated Radiation Therapy Era.
@nl
type
label
Pretreatment Serum Lactate Deh ...... dulated Radiation Therapy Era.
@en
Pretreatment Serum Lactate Deh ...... dulated Radiation Therapy Era.
@nl
prefLabel
Pretreatment Serum Lactate Deh ...... dulated Radiation Therapy Era.
@en
Pretreatment Serum Lactate Deh ...... dulated Radiation Therapy Era.
@nl
P2093
P2860
P356
P1476
Pretreatment Serum Lactate Deh ...... odulated Radiation Therapy Era
@en
P2093
Jingfeng Zong
Qiaojuan Guo
Shaojun Lin
Shenghua Zhan
Tianzhu Lu
Zhuhong Chen
P2860
P304
P356
10.12659/MSM.899531
P50
P577
2017-01-25T00:00:00Z